Illumina (ILMN) Financial Analysis & Valuation | Quarter Chart

Illumina (ILMN)

ILMN
Price: $181.1
Fair Value: 🔒
🔒score
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive he... more
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its p... more
Description Shares
Market Cap$27.40BExchangeNASDAQ
SectorHealthcareIndustryMedical - Diagnostics & Research
CountryUSCEOJacob Thaysen
IPO Date2000-07-28CAGR0.42%
Employees8,970Websitewww.illumina.com
Div. Yield—Payout Ratio—
Buy Back Yield1.52%Total Yield1.52%
ILMN chart loading...
Fundamentals Technicals
Enterprise Value$25.41BP/E Ratio36
Forward P/E30.53PEG Ratio5.39
P/S Ratio8.19P/B Ratio13.59
P/CF Ratio32.23P/FCF Ratio36.33
EPS$5.03EPS Growth 1Y—
EPS Growth 3Y—EPS Growth 5Y28.79%
Revenue Growth 1Y1.25%Gross Margin0.68%
Operating Margin0.21%Profit Margin0.19%
ROE0.34%ROA0.13%
ROCE0.19%Current Ratio1.75
Quick Ratio1.36Cash Ratio0.7
Debt/Equity0.92Interest Coverage12.39
Altman Z Score5.54Piotroski Score7

View Illumina financial charts →